| __timestamp | Mesoblast Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 25980000 | 759285000 |
| Thursday, January 1, 2015 | 23748000 | 862944000 |
| Friday, January 1, 2016 | 42548000 | 950751000 |
| Sunday, January 1, 2017 | 2412000 | 879387000 |
| Monday, January 1, 2018 | 17341000 | 661913000 |
| Tuesday, January 1, 2019 | 16722000 | 669893000 |
| Wednesday, January 1, 2020 | 32156000 | 644769000 |
| Friday, January 1, 2021 | 7456000 | 548970000 |
| Saturday, January 1, 2022 | 10211000 | 561347000 |
| Sunday, January 1, 2023 | 7501000 | 572952000 |
| Monday, January 1, 2024 | 5902000 | 629182000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, revenue is a key indicator of success. Mesoblast Limited and Taro Pharmaceutical Industries Ltd. have been vying for dominance in this arena since 2014. Over the past decade, Taro has consistently outperformed Mesoblast, boasting revenues that are approximately 40 times higher on average. In 2016, Taro reached its peak with a staggering 950 million, while Mesoblast's highest was a modest 42 million in the same year.
From 2014 to 2024, Taro's revenue has shown a steady decline, dropping by about 33% from its peak. Meanwhile, Mesoblast's revenue has fluctuated, with a notable dip in 2017. Despite these challenges, both companies continue to innovate and adapt in a rapidly changing market. As we look to the future, the question remains: can Mesoblast close the gap, or will Taro maintain its lead?
Revenue Showdown: Novartis AG vs Taro Pharmaceutical Industries Ltd.
Annual Revenue Comparison: argenx SE vs Mesoblast Limited
Breaking Down Revenue Trends: BeiGene, Ltd. vs Taro Pharmaceutical Industries Ltd.
Pharming Group N.V. vs Mesoblast Limited: Annual Revenue Growth Compared
Who Generates More Revenue? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: TG Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.
Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Novavax, Inc.
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.